ClinicalTrials.gg
RecruitingNCT07937345Updated Nov 16, 2026

Eccentric vs. Concentric Ankle Training in Multiple Sclerosis

An interventional study of Eccentric Ankle Dorsiflexor Elastic-Band Training and Concentric Ankle Dorsiflexor Elastic-Band Training in Multiple Sclerosis, sponsored by Al Hayah University In Cairo. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Al Hayah University In Cairo · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 50 studies in Multiple Sclerosis with a site in Egypt — 9 open to participants now, 12 under way, none of them phase 3. Multiple Sclerosis · Egypt.

Planned enrollment
12th of 28
54 · median 48
Started
2026
with 4 others
No phase
24 of 50
4 open now
Primary completion
2027-01
later than 9 of 11 live
Registered
50th of 50
by date
Lead sponsor
1 of 50
Al Hayah University In Cairo

Among the 50 studies in Multiple Sclerosis with a site in Egypt, this one is the 12th largest by planned enrollment of the 28 interventional ones that give a count, is one of 5 that started in 2026, is one of 24 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 50th registered.

Multiple Sclerosis

3,269 studies on the registry are indexed under Multiple Sclerosis; 663 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

9 of the 50 studies in Multiple Sclerosis with a site in Egypt are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 431 Multiple Sclerosis studies recruiting now, 163 (38%) set no upper age limit and 212 (49%) stop at 75 or younger; 40 take children under 18; 96 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Multiple Sclerosis with a site in Egypt, or all of them as a file.
02

Study summary

Multiple sclerosis is a chronic neurological disease that can cause muscle weakness, impaired walking, and difficulty controlling ankle movement. Foot drop is a common gait impairment in people with multiple sclerosis and occurs when weakness of the ankle dorsiflexor muscles limits the ability to lift the foot during walking.

This randomized controlled clinical trial aims to compare the effects of eccentric and concentric ankle dorsiflexor resistance training on ankle muscle strength and dynamic plantar pressure parameters during walking in adults with relapsing-remitting multiple sclerosis and foot drop.

A total of 54 participants are planned for enrollment. Eligible participants will be randomly allocated to two parallel groups, with 27 participants assigned to each group. The first group will perform eccentric ankle dorsiflexor training, while the second group will perform concentric ankle dorsiflexor training. Both groups will also receive the same standardized conventional physical therapy program.

The intervention will consist of three treatment sessions per week for six weeks, with each session lasting approximately 45 minutes. Ankle dorsiflexor resistance training will be performed using graded elastic resistance bands.

The primary outcome measures will be concentric and eccentric ankle dorsiflexor peak torque, assessed using a HUMAC NORM isokinetic dynamometer. Secondary outcome measures will include total plantar force, maximum plantar pressure, plantar contact surface area, and plantar contact time during walking, assessed using the DIERS pedoscan plantar pressure measurement system.

Measurements will be obtained before and after the six-week intervention period. The study will determine whether eccentric and concentric ankle dorsiflexor training produce different effects on muscle strength and dynamic plantar loading in individuals with multiple sclerosis and foot drop.

03

Conditions studied

  • Multiple Sclerosis

Browse trials for

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged between 20 and 40 years.
  • Clinically confirmed diagnosis of relapsing-remitting multiple sclerosis, based on neurological evaluation, MRI findings, and relevant medical records.
  • Medically stable multiple sclerosis without relapse during the preceding three months.
  • Clinically evident foot drop secondary to ankle dorsiflexor muscle weakness, with a manual muscle testing grade of 3/5 or less.
  • Expanded Disability Status Scale (EDSS) score between 1.0 and 6.0.
  • Ability to walk independently, with or without the participant's usual assistive device.
  • (MMSE) score between 25 and 30.
  • below 30 kg/m².
  • Willingness to participate in the study and provision of written .

Exclusion criteria

Exclusion Criteria:

  • Neurological disorders other than multiple sclerosis that could influence gait, including stroke, Parkinson's disease, peripheral neuropathy, or spinal cord injury.
  • Significant orthopedic disorders affecting the lower limbs or spine that could interfere with gait performance.
  • Recent lower-limb surgery or significant musculoskeletal injury.
  • Severe ankle spasticity that prevents appropriate performance of the dorsiflexor training protocol.
  • Severe balance impairment that makes participation in the training program unsafe.
  • Severe visual, vestibular, or cognitive impairment that prevents reliable study participation.
  • Significant cardiopulmonary disease or other medical conditions contraindicating physical exercise.
  • Current participation in a structured lower-limb strengthening program specifically targeting the ankle dorsiflexor muscles.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Eccentric Ankle Dorsiflexor Training

    Participants assigned to this group will receive eccentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to a standardized conventional physical therapy program. Eccentric exercise will emphasize controlled ankle movement from dorsiflexion toward plantarflexion against elastic resistance, with assisted or passive return to the starting position. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

    Behavioral: Eccentric Ankle Dorsiflexor Elastic-Band Training · Behavioral: standardized Conventional Physical Therapy for Multiple Sclerosis

  • Active comparator
    Concentric Ankle Dorsiflexor Training

    Participants assigned to this group will receive concentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to the same standardized conventional physical therapy program. Concentric exercise will emphasize active movement from plantarflexion toward dorsiflexion against elastic resistance, with an assisted or minimally resisted return movement. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

    Behavioral: Concentric Ankle Dorsiflexor Elastic-Band Training · Behavioral: standardized Conventional Physical Therapy for Multiple Sclerosis

Interventions

  • BehavioralEccentric Ankle Dorsiflexor Elastic-Band Training

    Participants will begin with the ankle positioned in dorsiflexion. A graded elastic resistance band attached to the forefoot will apply a plantarflexion-directed force. Participants will slowly control movement toward plantarflexion against band resistance, producing eccentric contraction of the ankle dorsiflexor muscles. Return to the starting position will be passive or assisted to minimize concentric dorsiflexor activity. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks. Band resistance will progress weekly according to participant tolerance and movement quality.

  • BehavioralConcentric Ankle Dorsiflexor Elastic-Band Training

    Participants will begin with the ankle positioned in plantarflexion. A graded elastic resistance band attached to the forefoot will oppose active dorsiflexion. Participants will actively move the ankle from plantarflexion toward dorsiflexion against resistance, producing concentric contraction of the ankle dorsiflexor muscles. Return toward plantarflexion will be assisted or performed with minimal resistance to minimize the eccentric training component. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks, with weekly progression based on tolerance and movement control.

  • Behavioralstandardized Conventional Physical Therapy for Multiple Sclerosis

    Both groups will receive identical conventional physical therapy consisting of upper-limb strengthening for shoulder and elbow muscle groups; flexibility exercises with 20-60-second stretching holds; postural correction; abdominal and trunk-extensor strengthening; relaxation and controlled breathing; and education on fatigue management and energy conservation. Upper-limb and trunk exercises will generally involve 5-10 repetitions with progression according to tolerance. Conventional therapy and ankle-specific resistance exercises will be delivered within 45-minute treatment sessions, three times weekly for six weeks.

06

What researchers measure

Primary outcomes

  1. Concentric Ankle Dorsiflexor Peak Torque (Nm)

    Maximum torque generated by the ankle dorsiflexor muscles during concentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal concentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

    Time frame: Baseline and at the end of the 6-week intervention.

  2. Eccentric Ankle Dorsiflexor Peak Torque (Nm)

    Maximum torque generated by the ankle dorsiflexor muscles during eccentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal eccentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

    Time frame: Baseline and at the end of the 6-week intervention.

Secondary outcomes

  1. Total Plantar Force During Walking (N)

    Total vertical force exerted by the foot on the pressure-sensitive platform during foot-ground contact while walking, measured using the DIERS pedoscan plantar pressure assessment system. Participants will walk barefoot across the platform at their self-selected comfortable walking speed. The measured force will be expressed in Newtons (N). Multiple walking trials will be completed, and mean values from valid trials will be used for analysis.

    Time frame: Baseline and at the end of the 6-week intervention.

  2. Maximum Plantar Pressure During Walking (N/cm²)

    The highest plantar pressure recorded at any location beneath the foot during the stance phase of walking, measured using the DIERS pedoscan plantar pressure system. Participants will walk barefoot across the pressure-sensitive platform at a self-selected comfortable speed. Maximum plantar pressure will be expressed in Newtons per square centimeter (N/cm²). Mean values from valid walking trials will be used for analysis.

    Time frame: Baseline and at the end of the 6-week intervention.

  3. Plantar Contact Surface Area During Walking (cm²)

    The area of the plantar surface that makes contact with the pressure-sensitive platform during walking, measured using the DIERS pedoscan plantar pressure assessment system. Plantar contact area will be expressed in square centimeters (cm²). Participants will walk barefoot at a self-selected comfortable walking speed, and mean values obtained from valid trials will be used for analysis.

    Time frame: Baseline and at the end of the 6-week intervention.

  4. Plantar Contact Time During Walking (ms)

    The duration of foot-ground contact during a step, measured using the DIERS pedoscan plantar pressure assessment system. Contact time will be expressed in milliseconds (ms). Participants will walk barefoot across the platform at a self-selected comfortable walking speed. Multiple trials will be completed, and the mean contact time from valid trials will be used for analysis.

    Time frame: Baseline and at the end of the 6-week intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 849 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 2 months is below that.

Counting every sponsor, half of 871 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 16, 2026
StartEst.
Nov 18, 2026
Primary completionEst.
Jan 18, 2027
CompletionEst.
Jan 18, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937345
Lead sponsor
Al Hayah University In Cairo
Responsible party
Sponsor
First posted
Nov 16, 2026
Start date
Nov 18, 2026 (estimated)
Primary completion
Jan 18, 2027 (estimated)
Completion
Jan 18, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Eslam N. Shoukry Fat-halla, BSc.
Contact
islam.nabil@ahuc.edu.eg
+201118219435

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion